Nutriband, Inc. Hits New 52-Week Low at $2.90 Amid Ongoing Struggles

Nutriband, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 2.90 as of June 18, 2026. This significant drop highlights ongoing challenges for the company, which has struggled with financial performance over the past year. The stock has seen a decline of 60.52% in its value over the last year, contrasting sharply with the S&P 500's performance of 25.41% during the same period. Nutriband's market capitalization stands at approximately USD 47 million, reflecting its microcap status. The company has reported negative results for three consecutive quarters, with net sales for the half-year at USD 0.83 million, down 36.32% year-over-year. Additionally, the net profit for the nine-month period was reported at a loss of USD 6.08 million, a decline of 30.17%. With a return on equity of -121.64% and a price-to-book ratio of 6.23, Nutriband's financial metrics indicate a challenging environment. The stock's performance has raised concerns about its management efficiency and overall market position.